Circulating Tumor Cell News and Research

RSS
Improvements in rare cell isolation and common blood tests

Improvements in rare cell isolation and common blood tests

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

Enzymatic sculpting process used to isolate and concentrate cells from whole blood

Enzymatic sculpting process used to isolate and concentrate cells from whole blood

Lung cancer patients can be screened for ALK-inhibitor suitability

Lung cancer patients can be screened for ALK-inhibitor suitability

Affymetrix second quarter total revenue increases to $66.4 million

Affymetrix second quarter total revenue increases to $66.4 million

BioView, ScreenCell enter collaboration agreement for imaging of CTC

BioView, ScreenCell enter collaboration agreement for imaging of CTC

New optical microscope identifies rare breast cancer cells

New optical microscope identifies rare breast cancer cells

New treatment target against metastatic pancreatic cancer

New treatment target against metastatic pancreatic cancer

Unifying theory on causes of cancer metastases

Unifying theory on causes of cancer metastases

New microfluidic device can sort cancer cells, particles

New microfluidic device can sort cancer cells, particles

Transgenomic introduces ICE COLD-PCR mutation detection technology

Transgenomic introduces ICE COLD-PCR mutation detection technology

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

Fluxion Biosciences announces launch of Discovery Services business

Fluxion Biosciences announces launch of Discovery Services business

ScreenCell, Affymetrix partner to distribute CTC platform

ScreenCell, Affymetrix partner to distribute CTC platform

New microfluidic device can harvest rare circulating tumor cells from blood

New microfluidic device can harvest rare circulating tumor cells from blood

Scientists use two different methods to visualize rare CTCs, double positive cells in mBC

Scientists use two different methods to visualize rare CTCs, double positive cells in mBC

Lilly announces results of three preclinical studies that focus on c-MET receptor

Lilly announces results of three preclinical studies that focus on c-MET receptor